Cargando…
Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” [Bioorg. Med. Chem. Lett. 29(8) (2019) 995–1000]
Autores principales: | Goncalves, Maria B., Clarke, Earl, Jarvis, Christopher I., Kalindjian, S. Barret, Pitcher, Thomas, Grist, John, Hobbs, Carl, Carlstedt, Thomas, Jack, Julian, Brown, Jane T., Mills, Mark, Mumford, Peter, Borthwick, Alan D., Corcoran, Jonathan P.T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697254/ https://www.ncbi.nlm.nih.gov/pubmed/31208764 http://dx.doi.org/10.1016/j.bmcl.2019.05.058 |
Ejemplares similares
-
Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury
por: Goncalves, Maria B., et al.
Publicado: (2019) -
Corrigendum to “Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA(A) receptor ligands” [Bioorg. Med. Chem. Lett. 25/2 (2015) 400–403]
por: Rycek, Lukas, et al.
Publicado: (2015) -
Corrigendum to “Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues” [Bioorg. Med. Chem. Lett. 23 (2013) 6019–6024]
por: Large, Jonathan M., et al.
Publicado: (2014) -
Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review
por: Borthwick, Alan D., et al.
Publicado: (2020) -
Corrigendum to “Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa” [Bioorg. Med. Chem. 21 (2013) 3051–3057]
por: Cho, Jung Keun, et al.
Publicado: (2013)